Back to search

Article

Fluvoxamine maleate ameliorates Alzheimer disease pathology by mitigating amyloid-beta load and neuroinflammation in 5XFAD mice

2023-12-18

Abstract excerpt

<h4>Background</h4> Alzheimer pathology (AD) is accompanied by the deposition of amyloid beta (Aβ) and chronic neuroinflammation, where NLRP3 inflammasome is particularly involved. In this study, we found that the OCD drug fluvoxamine maleate (FXN) can potently ameliorate AD pathology in 5XFAD mice by autophagy-mediated clearance of Aβ and inhibition of NLRP3 inflammasome. <h4>Methods</h4> We used mice primary a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ea49e043-959b-5020-b23b-2f1f968576c2
DOI
10.1101/2023.12.17.572086
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fluvoxamine maleate ameliorates Alzheimer disease pathology by mitigating amyloid-beta load and neuroinflammation in 5XFAD miceDOI 10.1101/2023.12.17.572086
Select a neighboring publication to make it the new centre.